{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:19:46Z","timestamp":1793996386909,"version":"4.8.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272421"],"award-info":[{"award-number":["82272421"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03900-2","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:45:56Z","timestamp":1766076356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NUP85 siRNA loaded red blood cell-derived extracellular vesicles alleviate hepatic steatosis in MASLD"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"3900_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001147","author":"Z Pang","year":"2024","unstructured":"Pang Z, Zhang H, Zheng S, Yang X, Liu C, Han Q, et al. HNF4\u03b1-CDKL3 axis restricts MASLD progression by targeting FoxO1 via noncanonical phosphorylation. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000001147.","journal-title":"Hepatology"},{"issue":"3","key":"3900_CR2","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","volume":"163","author":"MT Long","year":"2022","unstructured":"Long MT, Noureddin M, Lim JK. AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals. Expert Rev Gastroenterol. 2022;163(3):764\u201374. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.023.","journal-title":"Expert Rev Gastroenterol"},{"issue":"1","key":"3900_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05434-6","volume":"81","author":"Z Wan","year":"2024","unstructured":"Wan Z, Liu X, Yang X, Huang Z, Chen X, Feng Q, et al. MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2\/FOXO3 axis. Cell Mol Life Sci. 2024;81(1):398. https:\/\/doi.org\/10.1007\/s00018-024-05434-6.","journal-title":"Cell Mol Life Sci"},{"key":"3900_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16117","author":"SA Polyzos","year":"2024","unstructured":"Polyzos SA, Targher G. Hepatic thyroid hormone receptor-\u03b2 signalling: mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitis. Diabetes Obes Metab. 2024. https:\/\/doi.org\/10.1111\/dom.16117.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"3900_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3748\/wjg.v25.i11.1307","volume":"25","author":"JH Zhou","year":"2019","unstructured":"Zhou JH, Cai JJ, She ZG, Li HL. Noninvasive evaluation of nonalcoholic fatty liver disease: current evidence and practice. World J Gastroenterol. 2019;25(11):1307\u201326. https:\/\/doi.org\/10.3748\/wjg.v25.i11.1307.","journal-title":"World J Gastroenterol"},{"key":"3900_CR6","doi-asserted-by":"publisher","first-page":"1124886","DOI":"10.3389\/fneur.2023.1124886","volume":"14","author":"E Ravindran","year":"2023","unstructured":"Ravindran E, Lesca G, Januel L, Goldgruber L, Dickmanns A, Margot H, et al. Case report: compound heterozygous NUP85 variants cause autosomal recessive primary microcephaly. Front Neurol. 2023;14:1124886. https:\/\/doi.org\/10.3389\/fneur.2023.1124886.","journal-title":"Front Neurol"},{"issue":"2","key":"3900_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrm.2016.147","volume":"18","author":"M Beck","year":"2017","unstructured":"Beck M, Hurt E. The nuclear pore complex: understanding its function through structural insight. Nat Rev Mol Cell Biol. 2017;18(2):73\u201389. https:\/\/doi.org\/10.1038\/nrm.2016.147.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3900_CR8","doi-asserted-by":"publisher","first-page":"1514367","DOI":"10.3389\/fphar.2024.1514367","volume":"15","author":"KM Li","year":"2024","unstructured":"Li KM, Meng LF, Yang ZH, Hu WT. NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression. Front Pharmacol. 2024;15:1514367. https:\/\/doi.org\/10.3389\/fphar.2024.1514367.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3900_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41467-020-14338-5","volume":"11","author":"Y Terashima","year":"2020","unstructured":"Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11(1):609. https:\/\/doi.org\/10.1038\/s41467-020-14338-5.","journal-title":"Nat Commun"},{"issue":"5","key":"3900_CR10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/liv.15547","volume":"43","author":"M Zhang","year":"2023","unstructured":"Zhang M, Tian SY, Ma SY, Zhou X, Zheng XH, Li B, et al. <article-title update=\"added\">Deficient <scp>chaperone\u2010mediated<\/scp>autophagy in macrophage aggravates inflammation of nonalcoholic steatohepatitis by targeting Nup85. Liver Int. 2023;43(5):1021\u201334. https:\/\/doi.org\/10.1111\/liv.15547.","journal-title":"Liver Int"},{"key":"3900_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122714","volume":"349","author":"K Yang","year":"2024","unstructured":"Yang K, Yu X, Guo Z, Fang Z, Zhang H, Zhang W, et al. PIM1 alleviated liver oxidative stress and NAFLD by regulating the NRF2\/HO-1\/NQO1 pathway. Life Sci. 2024;122714. https:\/\/doi.org\/10.1016\/j.lfs.2024.122714.","journal-title":"Life Sci"},{"key":"3900_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111110","volume":"398","author":"J He","year":"2024","unstructured":"He J, Qian YC, Yin YC, Kang JR, Pan TR. Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms-a network pharmacology and experimental investigation. Chem Biol Interact. 2024;111110. https:\/\/doi.org\/10.1016\/j.cbi.2024.111110.","journal-title":"Chem Biol Interact"},{"key":"3900_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.12.029","author":"MC Xiao","year":"2024","unstructured":"Xiao MC, Jiang N, Chen LL, Liu F, Liu SQ, Ding CH, et al. TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4\u03b1 stability. J Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.jhep.2023.12.029.","journal-title":"J Hepatol"},{"issue":"6","key":"3900_CR14","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.7150\/ijbs.92337","volume":"20","author":"YC Wu","year":"2024","unstructured":"Wu YC, Yan Q, Yue SQ, Pan LX, Yang DS, Tao LS, et al. NUP85 alleviates lipid metabolism and inflammation by regulating PI3K\/AKT signaling pathway in nonalcoholic fatty liver disease. Int J Biol Sci. 2024;20(6):2219\u201335. https:\/\/doi.org\/10.7150\/ijbs.92337.","journal-title":"Int J Biol Sci"},{"key":"3900_CR15","doi-asserted-by":"publisher","unstructured":"Cao L, Du M, Cai M, Feng Y, Miao J, Sun J, et al. Neutrophil membrane-coated nanoparticles for targeted delivery of toll-like receptor 4 siRNA ameliorate LPS-induced acute lung injury. Int J Pharm. 2024;124960. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124960.","DOI":"10.1016\/j.ijpharm.2024.124960"},{"key":"3900_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.10.027","author":"CM Jogdeo","year":"2024","unstructured":"Jogdeo CM, Panja S, Kumari N, Tang W, Kapoor E, Siddhanta K, et al. Inulin-based nanoparticles for targeted siRNA delivery in acute kidney injury. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.10.027.","journal-title":"J Control Release"},{"key":"3900_CR17","doi-asserted-by":"publisher","unstructured":"Kalaimani K, Balachandran S, Boopathy LK, Roy A, Jayachandran B, Sankaranarayanan S, et al. Recent advancements in small interfering RNA (siRNA) based therapeutic approach on breast cancer. Eur J Pharmacol. 2024;176877. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176877.","DOI":"10.1016\/j.ejphar.2024.176877"},{"issue":"30","key":"3900_CR18","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.18632\/oncotarget.26880","volume":"10","author":"K Taniuchi","year":"2019","unstructured":"Taniuchi K, Yawata T, Tsuboi M, Ueba T, Saibara T. Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors. Oncotarget. 2019;10(30):2869\u201386. https:\/\/doi.org\/10.18632\/oncotarget.26880.","journal-title":"Oncotarget"},{"key":"3900_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.07.011","author":"Y Lyu","year":"2024","unstructured":"Lyu Y, Yang X, Yang L, Dai J, Qin H, Zhou Y, et al. Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease. J Control Release. 2024. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.011.","journal-title":"J Control Release"},{"issue":"2","key":"3900_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102184","volume":"35","author":"S Li","year":"2024","unstructured":"Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J, et al. Oligonucleotide therapies for nonalcoholic steatohepatitis. Mol Ther Nucleic Acids. 2024;35(2):102184. https:\/\/doi.org\/10.1016\/j.omtn.2024.102184.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3900_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2023.04.043","volume":"358","author":"L Xu","year":"2023","unstructured":"Xu L, Xu X, Liang Y, Wen C, Ouyang K, Huang J, et al. Osteoclast-targeted delivery of anti-miRNA oligonucleotides by red blood cell extracellular vesicles. J Control Release. 2023;358:259\u201372. https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.043.","journal-title":"J Control Release"},{"issue":"5","key":"3900_CR22","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.ymthe.2023.03.036","volume":"31","author":"B Peng","year":"2023","unstructured":"Peng B, Yang Y, Wu Z, Tan R, Pham TT, Yeo EYM, et al. Red blood cell extracellular vesicles deliver therapeutic SiRNAs to skeletal muscles for treatment of cancer cachexia. Mol Ther. 2023;31(5):1418\u201336. https:\/\/doi.org\/10.1016\/j.ymthe.2023.03.036.","journal-title":"Mol Ther"},{"issue":"4","key":"3900_CR23","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1007\/s11033-012-2306-4","volume":"40","author":"R Qi","year":"2013","unstructured":"Qi R, Feng M, Tan X, Gan L, Yan G, Sun C. FATP1 silence inhibits the differentiation and induces the apoptosis in chicken preadipocytes. Mol Biol Rep. 2013;40(4):2907\u201314. https:\/\/doi.org\/10.1007\/s11033-012-2306-4.","journal-title":"Mol Biol Rep"},{"issue":"36","key":"3900_CR24","doi-asserted-by":"publisher","first-page":"34268","DOI":"10.1074\/jbc.M300043200","volume":"278","author":"O Gavrilova","year":"2003","unstructured":"Gavrilova O, Haluzik M, Matsusue K, Cutson JJ, Johnson L, Dietz KR, Nicol CJ, Vinson C, Gonzalez FJ, Reitman ML. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem. 2003;278(36):34268\u201376. https:\/\/doi.org\/10.1074\/jbc.M300043200.","journal-title":"J Biol Chem"},{"key":"3900_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejca.2022.06.051","volume":"173","author":"JA Thomas","year":"2022","unstructured":"Thomas JA, Kendall BJ, Dalais C, Macdonald GA, Thrift AP. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Cancer. 2022;173:250\u201362. https:\/\/doi.org\/10.1016\/j.ejca.2022.06.051.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3900_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12935-021-01857-4","volume":"21","author":"R Xia","year":"2021","unstructured":"Xia R, Tang H, Shen J, Xu S, Liang Y, Zhang Y, et al. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population. Cancer Cell Int. 2021;21(1):154. https:\/\/doi.org\/10.1186\/s12935-021-01857-4.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"3900_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00432-024-05881-5","volume":"150","author":"Y Li","year":"2024","unstructured":"Li Y, Zhu J, Zhai F, Kong L, Li H, Jin X. Advances in the understanding of nuclear pore complexes in human diseases. J Cancer Res Clin Oncol. 2024;150(7):374. https:\/\/doi.org\/10.1007\/s00432-024-05881-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"3900_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03735-1","volume":"16","author":"Z Chen","year":"2025","unstructured":"Chen Z, Guan H, Chen L, Yuan X, Sun W, Chen M. Comprehensive pan-cancer evaluation of NUP85 prognosis, immune infiltration response, and validation in prostate cancer. Discov Oncol. 2025;16(1):1953. https:\/\/doi.org\/10.1007\/s12672-025-03735-1.","journal-title":"Discov Oncol"},{"issue":"6","key":"3900_CR29","first-page":"508","volume":"40","author":"X Liu","year":"2024","unstructured":"Liu X, Ding Z, Wu H, Ma J, Lu J. [Analysis of correlation between high expression of nucleoporin 85 (NUP85) and immune cell infiltration in hepatocellular carcinoma]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40(6):508\u201319.","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"issue":"8","key":"3900_CR30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707. https:\/\/doi.org\/10.1016\/j.tem.2024.02.007.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"3900_CR31","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cgh.2021.05.062","volume":"20","author":"J Park","year":"2022","unstructured":"Park J, Le AK, Tseng TC, Yeh ML, Jun DW, Trinh H, et al. Progression rates by Age, Sex, Treatment, and disease activity by AASLD and EASL criteria: data for precision medicine. Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association. 2022;20(4):874\u2013e854. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.062.","journal-title":"Clin Gastroenterol Hepatology: Official Clin Pract J Am Gastroenterological Association"},{"issue":"Suppl 1","key":"3900_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/liv.13653","volume":"38","author":"P Bedossa","year":"2018","unstructured":"Bedossa P. <article-title update=\"added\">Diagnosis of non\u2010alcoholic fatty liver disease\/non\u2010alcoholic steatohepatitis: why liver biopsy is essential. Liver Int. 2018;38(Suppl 1):64\u20136. https:\/\/doi.org\/10.1111\/liv.13653.","journal-title":"Liver Int"},{"issue":"1","key":"3900_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05315-3","volume":"22","author":"J Wang","year":"2024","unstructured":"Wang J, Jia B, Miao J, Li D, Wang Y, Han L, et al. An novel effective and safe model for the diagnosis of nonalcoholic fatty liver disease in China: gene excavations, clinical validations, and mechanism elucidation. J Transl Med. 2024;22(1):624. https:\/\/doi.org\/10.1186\/s12967-024-05315-3.","journal-title":"J Transl Med"},{"key":"3900_CR34","doi-asserted-by":"publisher","unstructured":"Liu T, Sui M, Tian M, Wu N, Zhao S, Wang Y et al. Sulfonated albumin from hepatocytes accelerates liver fibrosis in nonalcoholic fatty liver disease through Endoplasmic reticulum stress. Free radical biology & medicine. 2024. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.12.055","DOI":"10.1016\/j.freeradbiomed.2024.12.055"},{"issue":"1","key":"3900_CR35","doi-asserted-by":"publisher","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","volume":"16","author":"R Bened\u00e9-Ubieto","year":"2024","unstructured":"Bened\u00e9-Ubieto R, Cubero FJ, Nevzorova YA. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated steatotic liver disease (MASLD). Gut Microbes. 2024;16(1):2331460. https:\/\/doi.org\/10.1080\/19490976.2024.2331460.","journal-title":"Gut Microbes"},{"issue":"1","key":"3900_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","volume":"48","author":"G Musso","year":"2009","unstructured":"Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48(1):1\u201326. https:\/\/doi.org\/10.1016\/j.plipres.2008.08.001.","journal-title":"Prog Lipid Res"},{"issue":"8","key":"3900_CR37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/ni1222","volume":"6","author":"Y Terashima","year":"2005","unstructured":"Terashima Y, Onai N, Murai M, Enomoto M, Poonpiriya V, Hamada T, et al. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat Immunol. 2005;6(8):827\u201335. https:\/\/doi.org\/10.1038\/ni1222.","journal-title":"Nat Immunol"},{"key":"3900_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/biom13111670","author":"R Acharya","year":"2023","unstructured":"Acharya R, Shetty SS, Pavan G, Monteiro F, Munikumar M, Naresh S, et al. AI-based homology modelling of fatty acid transport protein 1 using AlphaFold: structural elucidation and molecular dynamics exploration. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13111670.","journal-title":"Biomolecules"},{"key":"3900_CR39","doi-asserted-by":"publisher","unstructured":"Jiang Y, Zhou X, He Z, Wei L, Zhu S, Zhang H, et al. DHA Improves neurodevelopmental abnormalities in offspring of gestational diabetes mellitus patients via the PPAR-\u03b3\/FATP4 pathway. Biochem Pharmacol. 2024;116726. https:\/\/doi.org\/10.1016\/j.bcp.2024.116726.","DOI":"10.1016\/j.bcp.2024.116726"},{"issue":"12","key":"3900_CR40","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1016\/j.psj.2020.09.086","volume":"99","author":"F Mu","year":"2020","unstructured":"Mu F, Jing Y, Ning B, Huang J, Cui T, Guo Y, You X, Yan X, Li H, Wang N. Peroxisome proliferator-activated receptor \u03b3 isoforms differentially regulate preadipocyte proliferation, apoptosis, and differentiation in chickens. Poult Sci. 2020;99(12):6410\u201321. https:\/\/doi.org\/10.1016\/j.psj.2020.09.086.","journal-title":"Poult Sci"},{"issue":"5","key":"3900_CR41","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/ATVBAHA.118.310797","volume":"38","author":"A Briot","year":"2018","unstructured":"Briot A, Decaunes P, Volat F, Belles C, Coupaye M, Ledoux S, et al. Senescence alters PPAR\u03b3 (Peroxisome Proliferator-Activated receptor Gamma)-dependent fatty acid handling in human adipose tissue microvascular endothelial cells and favors inflammation. Arterioscler Thromb Vasc Biol. 2018;38(5):1134\u201346. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310797.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"3900_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/apha.12665","volume":"217","author":"PG Blanchard","year":"2016","unstructured":"Blanchard PG, Turcotte V, C\u00f4t\u00e9 M, G\u00e9linas Y, Nilsson S, Olivecrona G, Deshaies Y, Festuccia WT. Peroxisome proliferator-activated receptor \u03b3 activation favours selective subcutaneous lipid deposition by coordinately regulating lipoprotein lipase modulators, fatty acid transporters and lipogenic enzymes. Acta Physiol (Oxf). 2016;217(3):227\u201339. https:\/\/doi.org\/10.1111\/apha.12665.","journal-title":"Acta Physiol (Oxf)"},{"key":"3900_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106497","volume":"152","author":"J Li","year":"2021","unstructured":"Li J, Tian J, Yin H, Peng Y, Liu S, Yao S, et al. Chemical conjugation of FITC to track silica nanoparticles in vivo and in vitro: an emerging method to assess the reproductive toxicity of industrial nanomaterials. Environ Int. 2021;152:106497. https:\/\/doi.org\/10.1016\/j.envint.2021.106497.","journal-title":"Environ Int"},{"issue":"9","key":"3900_CR44","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/nsmb.1474","volume":"15","author":"T Itoh","year":"2008","unstructured":"Itoh T, Fairall L, Amin K, Inaba Y, Szanto A, Balint BL, et al. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat Struct Mol Biol. 2008;15(9):924\u201331. https:\/\/doi.org\/10.1038\/nsmb.1474.","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"3900_CR45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s000110050622","volume":"49","author":"G Chinetti","year":"2000","unstructured":"Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res. 2000;49(10):497\u2013505. https:\/\/doi.org\/10.1007\/s000110050622.","journal-title":"Inflamm Res"},{"issue":"3","key":"3900_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101333","volume":"12","author":"X Li","year":"2025","unstructured":"Li X, Zhang H, Yu F, Xie S, Wang T, Zhang R, et al. IRF8 aggravates nonalcoholic fatty liver disease via BMAL1\/PPAR\u03b3 axis. Genes & Diseases. 2025;12(3):101333. https:\/\/doi.org\/10.1016\/j.gendis.2024.101333.","journal-title":"Genes & Diseases"},{"key":"3900_CR47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.4c01354","author":"J Li","year":"2025","unstructured":"Li J, Li C, Wu X, Dong Y, Li Y, Jiao X, et al. Protocatechuic acid suppresses lipid uptake and synthesis through the PPAR\u03b3 pathway in high-fat diet-induced NAFLD mice. J Agric Food Chem. 2025. https:\/\/doi.org\/10.1021\/acs.jafc.4c01354.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"3900_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2351620","volume":"16","author":"J Wei","year":"2024","unstructured":"Wei J, Luo J, Yang F, Feng X, Zeng M, Dai W, et al. Cultivated Enterococcus faecium B6 from children with obesity promotes nonalcoholic fatty liver disease by the bioactive metabolite tyramine. Gut microbes. 2024;16(1):2351620. https:\/\/doi.org\/10.1080\/19490976.2024.2351620.","journal-title":"Gut microbes"},{"issue":"9","key":"3900_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ani14091289","volume":"14","author":"P Zhang","year":"2024","unstructured":"Zhang P, Liu N, Xue M, Zhang M, Xiao Z, Xu C. \u03b2-sitosterol reduces the content of triglyceride and cholesterol in a high-fat diet-induced non-alcoholic fatty liver disease zebrafish (Danio rerio) model. Animals. 2024;14(9):1289. https:\/\/doi.org\/10.3390\/ani14091289.","journal-title":"Animals"},{"issue":"1","key":"3900_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","volume":"135","author":"V Ratziu","year":"2008","unstructured":"Ratziu V, Giral P, Jacqueminet S, et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with Rosiglitazone therapy (FLIRT) trial. Gastroenterology. 2008;135(1):100\u201310. https:\/\/doi.org\/10.1053\/j.gastro.2008.03.078.","journal-title":"Gastroenterology"},{"issue":"1","key":"3900_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13105-020-00777-7","volume":"77","author":"XX Ni","year":"2021","unstructured":"Ni XX, Li XY, Wang Q, Hua J. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-\u03b21\/Smad signaling pathway. J Physiol Biochem. 2021;77(1):35\u201345. https:\/\/doi.org\/10.1007\/s13105-020-00777-7.","journal-title":"J Physiol Biochem"},{"issue":"11","key":"3900_CR52","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/jgh.15025","volume":"35","author":"HM Wu","year":"2020","unstructured":"Wu HM, Ni XX, Xu QY, Wang Q, Li XY, Hua J. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4\/NF-\u03baB signaling pathway. J Gastroenterol Hepatol. 2020;35(11):1998\u20132008. https:\/\/doi.org\/10.1111\/jgh.15025.","journal-title":"J Gastroenterol Hepatol"},{"issue":"51","key":"3900_CR53","doi-asserted-by":"publisher","first-page":"51664","DOI":"10.1074\/jbc.M309377200","volume":"278","author":"EP Newberry","year":"2003","unstructured":"Newberry EP, Xie Y, Kennedy S, et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J Biol Chem. 2003;278(51):51664\u201372. https:\/\/doi.org\/10.1074\/jbc.M309377200.","journal-title":"J Biol Chem"},{"issue":"7","key":"3900_CR54","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"Cotter TG,","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u201364. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.052.","journal-title":"Gastroenterology"},{"issue":"5","key":"3900_CR55","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","volume":"23","author":"Q Tang","year":"2024","unstructured":"Tang Q, Khvorova A. RNAi-based drug design: considerations and future directions. Nat Rev Drug Discov. 2024;23(5):341\u201364. https:\/\/doi.org\/10.1038\/s41573-024-00912-9.","journal-title":"Nat Rev Drug Discov"},{"key":"3900_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113622","volume":"382","author":"L Xiong","year":"2025","unstructured":"Xiong L, Chen S, Li S, He D, Wang Y, Zhang Q, et al. ATP-responsive tumor targeted lipid nanoparticle for enhanced siRNA delivery and improved treatment efficacy in melanoma. J Control Release. 2025;113622. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113622.","journal-title":"J Control Release"},{"issue":"2","key":"3900_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nrd2742","volume":"8","author":"KA Whitehead","year":"2009","unstructured":"Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in SiRNA delivery. Nat Rev Drug Discov. 2009;8(2):129\u201338. https:\/\/doi.org\/10.1038\/nrd2742.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"3900_CR58","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00860-z","volume":"25","author":"J Byun","year":"2023","unstructured":"Byun J, Wu Y, Park J, Kim JS, Li Q, Choi J, et al. RNA nanomedicine: delivery strategies and applications. AAPS J. 2023;25(6):95. https:\/\/doi.org\/10.1208\/s12248-023-00860-z.","journal-title":"AAPS J"},{"key":"3900_CR59","doi-asserted-by":"publisher","first-page":"1444437","DOI":"10.3389\/fimmu.2024.1444437","volume":"15","author":"Z Song","year":"2024","unstructured":"Song Z, Tao Y, Liu Y, Li J. Advances in delivery systems for CRISPR\/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Front Immunol. 2024;15:1444437. https:\/\/doi.org\/10.3389\/fimmu.2024.1444437.","journal-title":"Front Immunol"},{"issue":"3","key":"3900_CR60","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","volume":"28","author":"HC Verdera","year":"2020","unstructured":"Verdera HC, Kuranda K, Mingozzi F. AAV vector immunogenicity in humans: a long journey to successful gene transfer. Mol Ther. 2020;28(3):723\u201346. https:\/\/doi.org\/10.1016\/j.ymthe.2019.12.010.","journal-title":"Mol Ther"},{"issue":"7","key":"3900_CR61","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","volume":"25","author":"PR Cullis","year":"2017","unstructured":"Cullis PR, Hope MJ. Lipid nanoparticle systems for enabling gene therapies. Mol Ther. 2017;25(7):1467\u201375. https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.013.","journal-title":"Mol Ther"},{"key":"3900_CR62","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c11858","author":"X Bian","year":"2025","unstructured":"Bian X, Zhou L, Luo Z, Liu G, Hang Z, Li H, Li F, Wen Y. Emerging delivery systems for enabling precision nucleic acid therapeutics. ACS Nano. 2025. https:\/\/doi.org\/10.1021\/acsnano.4c11858.","journal-title":"ACS Nano"},{"key":"3900_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040359","author":"TTH Thi","year":"2021","unstructured":"Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines (Basel). 2021. https:\/\/doi.org\/10.3390\/vaccines9040359.","journal-title":"Vaccines (Basel)"},{"key":"3900_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113888","volume":"176","author":"V Kumar","year":"2021","unstructured":"Kumar V, Xin X, Ma J, Tan C, Osna N, Mahato RI. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2021;176:113888. https:\/\/doi.org\/10.1016\/j.addr.2021.113888.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"3900_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41419-020-2571-4","volume":"11","author":"MM Woitok","year":"2020","unstructured":"Woitok MM, Zoubek ME, Doleschel D, Bartneck M, Mohamed MR, Kie\u00dfling F, et al. Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease. Cell Death Dis. 2020;11(5):343. https:\/\/doi.org\/10.1038\/s41419-020-2571-4.","journal-title":"Cell Death Dis"},{"key":"3900_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01563-4","author":"J Kim","year":"2023","unstructured":"Kim J, Eygeris Y, Ryals RC, Jozi\u0107 A, Sahay G. Strategies for non-viral vectors targeting organs beyond the liver. Nat Nanotechnol. 2023. https:\/\/doi.org\/10.1038\/s41565-023-01563-4.","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"3900_CR67","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1042\/BJ20111377","volume":"441","author":"GM Shen","year":"2012","unstructured":"Shen GM, Zhao YZ, Chen MT, Zhang FL, Liu XL, Wang Y, Liu CZ, Yu J, Zhang JW. Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia. Biochem J. 2012;441(2):675\u201383. https:\/\/doi.org\/10.1042\/BJ20111377.","journal-title":"Biochem J"},{"key":"3900_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","volume":"174","author":"L Barile","year":"2017","unstructured":"Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63\u201378. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.020.","journal-title":"Pharmacol Ther"},{"key":"3900_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030891","author":"HVM Spiers","year":"2023","unstructured":"Spiers HVM, Stadler LKJ, Smith H, Kosmoliaptsis V. Extracellular vesicles as drug delivery systems in organ transplantation: the next frontier. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15030891.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3900_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12030","volume":"10","author":"G Zhang","year":"2020","unstructured":"Zhang G, Huang X, Xiu H, Sun Y, Chen J, Cheng G, et al. Extracellular vesicles: natural liver-accumulating drug delivery vehicles for the treatment of liver diseases. J Extracell Vesicles. 2020;10(2):e12030. https:\/\/doi.org\/10.1002\/jev2.12030.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"3900_CR71","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1038\/s41467-018-04791-8","volume":"9","author":"WM Usman","year":"2018","unstructured":"Usman WM, Pham TC, Kwok YY, Vu LT, Ma V, Peng B, Chan YS, Wei L, Chin SM, Azad A, He AB, Leung AYH, Yang M, Shyh-Chang N, Cho WC, Shi J, Le MTN. Efficient RNA drug delivery using red blood cell extracellular vesicles. Nat Commun. 2018;9(1):2359. https:\/\/doi.org\/10.1038\/s41467-018-04791-8.","journal-title":"Nat Commun"},{"issue":"4","key":"3900_CR72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of SiRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135. https:\/\/doi.org\/10.1038\/nbt.1807.","journal-title":"Nat Biotechnol"},{"issue":"17","key":"3900_CR73","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1093\/nar\/gks463","volume":"40","author":"J Wahlgren","year":"2012","unstructured":"Wahlgren J, De LKT, Brisslert M, Vaziri Sani F, Telemo E, Sunnerhagen P, et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 2012;40(17):e130. https:\/\/doi.org\/10.1093\/nar\/gks463.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3900_CR74","doi-asserted-by":"publisher","first-page":"14610","DOI":"10.1038\/s41598-024-65623-y","volume":"14","author":"S Biagiotti","year":"2024","unstructured":"Biagiotti S, Canonico B, Tiboni M, Abbas F, Perla E, Montanari M, et al. Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules. Sci Rep. 2024;14(1):14610. https:\/\/doi.org\/10.1038\/s41598-024-65623-y.","journal-title":"Sci Rep"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03900-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03900-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03900-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:51:24Z","timestamp":1769169084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-03900-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3900"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03900-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments conducted in this study received approval from the Laboratory Animal Management and Ethics Committee of Jiangsu University (Approval Number: UJS-IACUC-AP-2022031502) and adhered strictly to the following international guidelines: the World Medical Association (WMA)\"Declaration on the Use of Animals in Biomedical Research,\" the 3R principles (Replacement, Reduction, Refinement) outlined in the EU Directive 2010\/63\/EU, and the Chinese national standard \"Guidelines for Ethical Review of Laboratory Animal Welfare.\" The patient samples\/data and healthy donor samples\/data collection used in this study were approved by the Research Ethics Committee of the Affiliated Wujin Hospital of Jiangsu University (Approval No: 2025-SR-019), and complied with the ethical guidelines of the Declaration of Helsinki. The acquisition of tissues used in this study conformed to the World Health Organization's Guiding Principles on Human Cell, Tissue, and Organ Transplantation. The risks posed by the study to the subjects are minimal, and waiving informed consent will not adversely affect their rights or health. This study does not utilize medical records or specimens that patients or subjects have explicitly declined to use previously. It is explicitly stated that no privacy or personal identity information of the subjects will be collected during the research process, and stringent measures are in place to ensure that such information remains confidential. The specimens involved in the clinical trials of diagnostic reagents consist of residual samples or specimens from a biobank, which have been used for medical diagnosis and treatment. These specimens have had all personal and identifiable information removed and are identified solely by codes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}